Bon Natural Life Plans To Launch New Multi-Functional Health Supplements

by Shivani Kumaresan, Benzinga Staff Writer

April 21, 2022 1:59 PM | 1 min read |

Bon Natural Life Ltd BON has developed new nutraceutical compounds, Glucoraphanin (GF) and Sulforaphane (SFN), extracted from cruciferous vegetables.
The compounds could provide immunity support and improve certain regulatory health functions.
The company plans to launch GF and SFN-based consumer products, including immune system boosters, digestive boosters, sleep aid products, and weight loss products, in the next six months.
The products will be launched through multiple sales channels, including direct sales to pharmacies and enterprise clients, e-commerce platforms, and distributors.
Price Action: BON shares are trading higher by 4.57% at $3.66 on the last check Thursday.

Posted In: News Penny Stocks Health Care General Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.